{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03729115",
            "orgStudyIdInfo": {
                "id": "IRB18-0970"
            },
            "organization": {
                "fullName": "University of Chicago",
                "class": "OTHER"
            },
            "briefTitle": "A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer",
            "officialTitle": "Chicago Alternative Prevention Study for Diverse Populations of High Risk Women",
            "acronym": "CAPS",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-multi-modality-surveillance-program-for-women-at-high-risk-for-breast-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-05-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-10-12",
            "studyFirstSubmitQcDate": "2018-10-31",
            "studyFirstPostDateStruct": {
                "date": "2018-11-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-01",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Chicago",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is aimed to establish a registry of women undergoing intensive surveillance for the early detection of breast cancer in high-risk women."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SCREENING",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Screening Arm",
                    "type": "OTHER",
                    "description": "Enrolled patients will undergo Magnetic Resonance Imaging (MRI) every 6 months (2x/year) in addition to an annual screening mammogram.",
                    "interventionNames": [
                        "Procedure: Magnetic Resonance Imaging (MRI)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Magnetic Resonance Imaging (MRI)",
                    "description": "Patients will have MRI scans every 6 months.",
                    "armGroupLabels": [
                        "Screening Arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Development of faster MRI protocols for a for a Personalized Risk-based Imaging Surveillance Model for diverse populations of high risk women.",
                    "description": "We will test whether an abbreviated MRI (AB-MRI) is diagnostically equivalent to a full MRI. Eligible women will be scanned every 6 months with a full protocol MRI.",
                    "timeFrame": "5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n- Known BRCA1 or BRCA2, TP53, PALB2, PTEN, CDH1 and STK11 carrier. Women with pathogenic mutations in any other cancer susceptibility genes are eligible only if they also have a high PRS.\n\nOR\n\n* With life time risk of 30% or higher, based on Polygenic Risk Score that integrates genetic and non-genetic factors OR\n* 5-years risk \u2265 6% for women 40-64 OR\n* 5-years risk \u2265 6% for women 65+ AND breast density C or D AND a lifetime risk \\>= 20% (BCSC+PRS LTR or Tyrer-Cuzick LTR) OR\n* Patients with history of chest wall radiation received before age 35. OR\n* To promote health equity, women of African Ancestry \\< 45 years with at least one 1st or 2nd degree relative with breast or ovarian cancer are eligible because PRS Scores are not currently reported for AA women.\n* Must be at least 25 years old.\n* Willing to travel to participating site for imaging studies as well as any necessary follow-up procedures.\n* Be able to give informed consent.\n\n  * Patients with prior history of breast or ovarian cancer are eligible if they have completed all active treatments and are cancer free for two years.\n\nExclusion Criteria\n\n* Undergoing active cancer treatment at the time of enrollment.\n* Current pregnancy or plans for pregnancy within two years of enrollment.\n* Presence of a pacemaker or any other metallic foreign object in their body that interferes with an MRI.\n* Breast surgery within two weeks of study entry.\n* Women with history of bilateral mastectomy are not eligible\n* History of kidney disease or abnormal kidney function.\n* History of dye allergy unless it can be mediated with antihistamines and/or steroids\n\n  * Women can be taking hormone replacement therapy, tamoxifen, raloxifene, aromatase inhibitors, Parp Inhibitors as adjuvant therapy or participating in a chemoprevention trial.",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "minimumAge": "25 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Cancer Clinical Intake Office",
                    "role": "CONTACT",
                    "phone": "1-855-702-8222",
                    "email": "cancerclinicaltrials@bsd.uchicago.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Olufunmilayo I Olopade, MD",
                    "affiliation": "University of Chicago",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University Of Chicago Medicine Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cancer Clinical Trials Intake",
                            "role": "CONTACT",
                            "phone": "855-702-8222",
                            "email": "cancerclinicaltrials@bsd.uchicago.edu"
                        },
                        {
                            "name": "Olufunmilayo Olopade, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}